Obstructive Sleep Apnea Syndrome (OSAS) is a chronic disease characterized by intermittent hypoxia and sleep fragmentation resulting from recurrent upper airway obstructions. The physiological and neurocognitive changes caused by the disease can affect how individuals perceive and interpret bodily sensations. Although body awareness plays a significant role in the perception and management of symptoms, its relationship with clinical parameters in individuals with OSAS has not been sufficiently investigated. Therefore, the aim of our study is to examine the relationship between body awareness and respiratory function, disease severity, fatigue, shortness of breath, and sleep quality in OSAS patients.
Study Type
OBSERVATIONAL
Enrollment
47
Karabük Training and Research Hospital
Karabük, Turkey (Türkiye)
Body awareness
The Body Awareness Questionnaire (BAQ) will be used to assess individuals' body awareness. The scale score ranges from 18 to 26, with higher scores indicating higher awareness.
Time frame: Baseline
Dyspnea
Dyspnea is assessed with the modified Medical Research Council (mMRC) dyspnea scale. As the score increases, shortness of breath increases.
Time frame: Baseline
Disease severity
The evaluation will be based on the Apnea/Hypopnea index measured by polysomnography. An Apnea-Hypopnea Index \>5 indicates Obstructive Sleep Apnea Syndrome.
Time frame: Baseline
Fatigue severity
Fatigue will be assessed using the Fatigue Severity Scale. A score of 36 or higher indicates severe fatigue.
Time frame: Baseline
Sleep quality
Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PUKI). The total score ranges from 0 to 21, and a score above 5 indicates poor sleep quality.
Time frame: Baseline
Pulmonary function (Forced vital capacity (FVC)
Pulmonary function will be evaluated using the spirometry, according to American Thoracic Society and European Respiratory Society criteria. Forced vital capacity (FVC) will be measured.
Time frame: Baseline
Pulmonary function (Forced expiratory volume in the first second (FEV1)
Pulmonary function will be evaluated using the spirometry, according to American Thoracic Society and European Respiratory Society criteria. Forced expiratory volume in the first second (FEV1) will be measured.
Time frame: Baseline
Pulmonary function (FEV1 / FVC)
Pulmonary function will be evaluated using the spirometry, according to American Thoracic Society and European Respiratory Society criteria. FEV1 / FVC will be measured.
Time frame: Baseline
Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%))
Pulmonary function will be evaluated using the spirometry, according to American Thoracic Society and European Respiratory Society criteria. Flow rate 25-75% of forced expiratory volume (FEF 25-75%) will be measured.
Time frame: Baseline
Pulmonary function (Peak flow rate (PEF))
Pulmonary function will be evaluated using the spirometry, according to American Thoracic Society and European Respiratory Society criteria. Peak flow rate (PEF) will be measured.
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.